Ionis Pharmaceuticals Inc. Common Stock vs W.R. Berkley Corporation Common Stock — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.32 (market cap $7.10B), while W.R. Berkley Corporation Common Stock trades at $74.74 (market cap $27.40B). The key difference: W.R. Berkley Corporation Common Stock is far larger — about 3.9× Ionis Pharmaceuticals Inc. Common Stock's market cap, and W.R. Berkley Corporation Common Stock pays a 0.54% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and W.R. Berkley Corporation Common Stock for 0 Days on average.
| IONS | WRB | |
|---|---|---|
Market Cap | $7.10B | $27.40B |
Volume | 2,027,457 | 2,015,378 |
Sector | Health | Financials |
52-Week High | $86.50 | $78.10 |
52-Week Low | $42.38 | $63.54 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.66B | $27.64B |
Dividend Yield | — | 0.54% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →W.R. Berkley Corporation is an insurance holding company that underwrites commercial property and casualty insurance and reinsurance through its Insurance and Reinsurance & Monoline Excess segments.
Read more on WRB →